Complex Aortic Valve Repair Provides a Durable and Effective Alternative to Valve Replacement in Children with Aortic Valve Disease
J. S. Tweddell, P. C. Frommelt, A. N. Pelech, R. D. Jaquiss, K. A. Mussatto, S. B. Litwin.
Medical College of Wisconsin, Children's Hospital of Wisconsin, Milwaukee, WI
BACKGROUND: Valve replacement options are limited in children. Can complex valve repair provide a durable and effective option?
METHODS:Retrospective review of surgery for aortic valve disease(1973-2003).
RESULTS:In 278 patients with aortic valve disease, 101 pts. required either valve replacement (AVR) or complex repair. Primary diagnosis was AS(35%), AI(46%) or combined AS/AI(19%). AVR was performed in 48 using mechanical(n=22), homograft(n=9), or autograft(n=17) valves. Complex repairs(n=53) included commissurotomy and additional surgical techniques including leaflet thinning(17), suspension(21), extension(6), fenestration repair(9), supravalvar augmentation(8) or relief of subAS(10). Actuarial freedom from mortality or reintervention for all was: 1yr-90±3%, 5yrs-77±6%, and 10yrs-51±10%. Comparing the group undergoing valve repair to those with AVR, repair patients were younger(9.9±8.1 vs. 14±7.2yrs), more likely to have AS as their primary diagnosis(49% vs. 19%), and had higher preoperative gradients across the valve(75±23 vs. 49±31mmHg), all p<.05. Presence of combined AS/AI did not predict poor outcome. On follow-up ECHO at a mean duration of 3.2yrs post-repair, valve repair pts. had a mean gradient of 20±19mmHg and 87% had mild or less AI. Operative survival was 100% for valve repair compared to 88.7% for AVR(p<.05). Actuarial freedom from mortality or reintervention was not different between groups(p=.59); at 5yrs post-op, valve repair-79±8% vs. AVR-75±9%.
CONCLUSIONS:Intermediate follow-up in pts. undergoing aortic valve repair indicates this is an option for children with aortic valve disease, including those with mixed AS/AI. Repair is advantageous because it alleviates need for long-term anticoagulation, maintains growth potential of the aortic root and delays valve replacement. Furthermore, the autograft option remains open.
Back to Final Program